Search This Blog

Monday, May 10, 2021

NOVARTIS AG: Receives Buy rating from UBS

 Analyst Laura Sutcliffe from UBS research considers the stock attractive and recommends it with a Buy rating. The target price remains unchanged at CHF 96.

https://www.marketscreener.com/quote/stock/NOVARTIS-AG-9364983/news/NOVARTIS-AG-nbsp-Receives-a-Buy-rating-from-UBS-33209459/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.